Sonorous Neurovascular announced today that it received FDA 510(k) clearance for its BosCATH next-generation neurovascular ...
Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced that it has received 510(k) ...
Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...
LAKE FOREST, Calif., March 27, 2026 /PRNewswire/ -- Sonorous NV, Inc. today announced management changes pursuant to which Paul Brooke, a current Board member, has become Chairman of the Board. In ...
Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced that it has received 510(k) ...